Reed Elsevier PLC
06 August 2004
ISSUED ON BEHALF OF REED ELSEVIER PLC AND REED ELSEVIER NV
DIRECTOR SHAREHOLDING
We have received notification today of the following sale of securities in Reed
Elsevier PLC and Reed Elsevier NV, by Mr A Prozes, a director of Reed Elsevier
PLC and Reed Elsevier NV.
Reed Elsevier PLC
2,017 ADRs (representing 8,068 Reed Elsevier PLC ordinary shares) were sold
between 5 and 6 August 2004 at an average price of US$34.97 per ADR.
Reed Elsevier NV
14,040 ordinary shares were sold on 5 August 2004 at a price of €10.63 per
share.
Mr Prozes is selling the above shares as a consequence of his divorce
settlement. Following the transaction, Mr Prozes still holds an interest in
102,809 Reed Elsevier PLC ordinary shares and 63,454 Reed Elsevier NV ordinary
shares.
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.